Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Price Target at $9.88

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been assigned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $9.88.

A number of analysts have recently issued reports on BIOX shares. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research report on Thursday, February 13th. Lake Street Capital cut their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Finally, Oppenheimer cut their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, January 28th.

Hedge Funds Weigh In On Bioceres Crop Solutions

Large investors have recently made changes to their positions in the company. Bank of America Corp DE increased its stake in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares during the period. Jump Financial LLC bought a new position in Bioceres Crop Solutions during the 4th quarter worth $72,000. Northern Trust Corp bought a new position in Bioceres Crop Solutions during the 4th quarter worth $93,000. Maven Securities LTD bought a new position in Bioceres Crop Solutions during the 4th quarter worth $152,000. Finally, Stifel Financial Corp increased its stake in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after acquiring an additional 10,224 shares during the period. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Performance

BIOX opened at $5.19 on Wednesday. Bioceres Crop Solutions has a 12-month low of $3.69 and a 12-month high of $13.25. The stock has a market cap of $325.47 million, a price-to-earnings ratio of 259.63 and a beta of 0.73. The business has a 50 day moving average of $5.87 and a 200-day moving average of $6.98. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.